JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

NCT07384377 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2-positive Colorectal Cancer

Interventions

DRUG: JSKN003
DRUG: Physician choiced treatment, include: TAS-102, Regorafenib, Fruquintinib.

Sponsor

Shanghai JMT-Bio Inc.